Crohn's and Colitis Center

The Massachusetts General Hospital Digestive Healthcare Center’s Crohn’s and Colitis Center is one of the few comprehensive, multidisciplinary programs in New England dedicated to the diagnosis and treatment of patients with Crohn’s disease and ulcerative colitis.
Request an appointment

Call to request an appointment or refer a patient: 617-724-6005

Overview

Care for All Ages

Crohn’s disease and ulcerative colitis are lifelong diseases, and we treat patients of all ages. Our MassGeneral Hospital for Children pediatric specialists help parents address the special concerns of growth and physical and social development in their children and assist their adolescent patients in making a smooth transition to adult medical care at the appropriate time.

State-of-the-Art Treatment Options

We offer a full range of conventional, innovative and investigational medical therapies and surgical procedures for Crohn’s disease and ulcerative colitis.

Our services include:

  • Medical and surgical office consultations, including second opinions
  • Endosocopy
  • Infusion therapy
  • Psychiatry
  • Support groups and onsite library
  • Nutritional counseling
  • Access to new therapies through clinical trials
  • Enterostomal consultations, evaluations, treatment and ongoing support

Whenever possible, multiple appointments are scheduled for the same visit.

Second Opinions

Many patients are referred to the Crohn's and Colitis Center for a second opinion consultation from one of our world-class physicians. Patients benefit most from obtaining a second opinion because our physicians review each patient's previously assessed condition and discuss the full range of available treatments. Contact our access coordinator to schedule a consultation

A Dedicated Referral Line for Physicians and Patients 

We provide patients and referring physicians with an experienced access coordinator, a clinician who helps assess patient needs, coordinate appointments and begin the appropriate testing regimen. Calls will be returned within 24 hours. Contact the Crohn's and Colitis Center’s access coordinator

Access to Clinical Trials

Our physicians are active in clinical trials and research studies related to new therapies for inflammatory bowel diseases, allowing us to bring our patients promising new treatments as quickly as possible.

Our patients can also choose to participate in an ongoing landmark study of Crohn’s disease and ulcerative colitis, known as PRISM. Through PRISM, we are investigating the genetic causes of IBD, with a goal of identifying markers that will predict the course of a patient’s disease. This information will benefit patients by leading to better diagnostic tests and new treatments.

Patients interested in participating in clinical trials canbrowse online for open trials.

Advancing Crohn’s and IBD Treatment Through Ongoing Research

The Crohn’s and Colitis Center’s specialists are advancing research on Crohn's and IBD treatment. Ramnik Xavier, MD, was the coauthor of a landmark publication that described 30 new genes that may contribute to Crohn’s disease. Richard Hodin,MD,  director of the Laboratory of Gastrointestinal Epithelial Biology, is investigating a promising new therapy for IBD called intestinal alkaline phosphatase.

We are part of The Center for the Study of IBD, a multimillion dollar National Institutes of Health-funded program devoted to finding new treatments for inflammatory bowel diseases. We are also performing extensive research on the role of bacteria in the digestive track and the genetic factors that cause Crohn’s and colitis.

Annual Symposium Advances Understanding of Inflammatory Bowel Disease

We host an internationally recognized annual symposium on inflammatory bowel disease. The symposium draws experts from around the world who share their expertise and explore the latest advances in the causes of Crohn’s disease and ulcerative colitis.

About this Program

Care for All Ages

Crohn’s disease and ulcerative colitis are lifelong diseases, and we treat patients of all ages. Our MassGeneral Hospital for Children pediatric specialists help parents address the special concerns of growth and physical and social development in their children and assist their adolescent patients in making a smooth transition to adult medical care at the appropriate time.

State-of-the-Art Treatment Options

We offer a full range of conventional, innovative and investigational medical therapies and surgical procedures for Crohn’s disease and ulcerative colitis.

Our services include:

  • Medical and surgical office consultations, including second opinions
  • Endosocopy
  • Infusion therapy
  • Psychiatry
  • Support groups and onsite library
  • Nutritional counseling
  • Access to new therapies through clinical trials
  • Enterostomal consultations, evaluations, treatment and ongoing support

Whenever possible, multiple appointments are scheduled for the same visit.

Second Opinions

Many patients are referred to the Crohn's and Colitis Center for a second opinion consultation from one of our world-class physicians. Patients benefit most from obtaining a second opinion because our physicians review each patient's previously assessed condition and discuss the full range of available treatments. Contact our access coordinator to schedule a consultation

A Dedicated Referral Line for Physicians and Patients 

We provide patients and referring physicians with an experienced access coordinator, a clinician who helps assess patient needs, coordinate appointments and begin the appropriate testing regimen. Calls will be returned within 24 hours. Contact the Crohn's and Colitis Center’s access coordinator

Access to Clinical Trials

Our physicians are active in clinical trials and research studies related to new therapies for inflammatory bowel diseases, allowing us to bring our patients promising new treatments as quickly as possible.

Our patients can also choose to participate in an ongoing landmark study of Crohn’s disease and ulcerative colitis, known as PRISM. Through PRISM, we are investigating the genetic causes of IBD, with a goal of identifying markers that will predict the course of a patient’s disease. This information will benefit patients by leading to better diagnostic tests and new treatments.

Patients interested in participating in clinical trials can browse online for open trials.

Advancing Crohn’s and IBD Treatment Through Ongoing Research

The Crohn’s and Colitis Center’s specialists are advancing research on Crohn's and IBD treatment. Ramnik Xavier, MD, was the coauthor of a landmark publication that described 30 new genes that may contribute to Crohn’s disease. Richard Hodin,MD,  director of the Laboratory of Gastrointestinal Epithelial Biology, is investigating a promising new therapy for IBD called intestinal alkaline phosphatase.

We are part of The Center for the Study of IBD, a multimillion dollar National Institutes of Health-funded program devoted to finding new treatments for inflammatory bowel diseases. We are also performing extensive research on the role of bacteria in the digestive track and the genetic factors that cause Crohn’s and colitis.

Annual Symposium Advances Understanding of Inflammatory Bowel Disease

We host an internationally recognized annual symposium on inflammatory bowel disease. The symposium draws experts from around the world who share their expertise and explore the latest advances in the causes of Crohn’s disease and ulcerative colitis.

Conditions & Diseases

  • Celiac Disease

    Celiac disease is a digestive disease that damages the small intestine because of a sensitivity to gluten, which is found in wheat, rye, barley, and oats. This hereditary disorder interferes with the absorption of nutrients from food.

  • Crohn's Disease

    Crohn's disease is an inflammatory bowel disease that is a chronic condition that may recur at various times over a lifetime.

  • Ulcerative Colitis

    Ulcerative colitis is an inflammatory bowel disease in which the inner lining of the large intestine (colon or bowel) and rectum become inflamed.

Clinical Trials

Contact

Contact Us

Crohn's and Colitis Center

CRP 9

165 Cambridge Street Boston, MA 02114
  • Phone: 617-724-6005

Hours

  • 8:00 am to 5:00 pm, Monday through Friday

To begin the appointment process, contact the Crohn's and Colitis Center access coordinator at 617-724-6005 or request an appointment online.

Request an appointment

Call to request an appointment or refer a patient: 617-724-6005

Back to Top